264:(HGP), using about $ 300 million of private funding versus approximately $ 3 billion of taxpayer dollars. However, a significant portion of the human genome had already been sequenced when Celera entered the field, and thus Celera did not incur any costs with obtaining the existing data, which was freely available to the public from
527:
Five years ago, Craig Venter let out a big secret. As president of Celera
Genomics, Venter had led the race between his company and a government-funded project to decode the human genome. After leaving Celera in 2002, Venter announced that much of the genome that had been sequenced there was his
38:
280:
policy for gene sequences from the publicly funded Human Genome
Project. Later, the company changed their policy and made their sequences available for non-commercial use but set a maximum threshold for amount of sequence data that a researcher could download at any given time.
275:
Critics of initial efforts by Celera
Genomics to hold back data from sections of genome they sequenced for commercial exploitation felt that it would retard progress in science as a whole. These critics pointed to the
617:
Venter discusses Celera's progress in deciphering the human genome sequence and its relationship to healthcare and to the federally funded Human Genome
Project.
665:
655:
640:
645:
366:
288:
by James
Shreeve, who followed Venter around for two years in the process of writing the book. A view from the public effort's side is that of
614:
660:
670:
572:
539:
635:
393:
225:
284:
The rise and fall of Celera as an ambitious competitor of the Human Genome
Project is the main subject of the book
650:
17:
555:
Shabana, Ayman (2019). "Living with the Genome, by Angus Clark and Flo
Ticehurst, within the Muslim Context".
249:. Celera was formed for the purpose of generating and commercializing genomic information. Its stock is a
188:
which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of
123:
272:, spurred the public HGP to accelerate its effort and shift its projected timetable from 2005 to 2003.
370:
277:
516:
322:
242:
521:
448:
479:
261:
8:
213:
205:
99:
483:
445:
436:
411:
269:
254:
568:
497:
441:
339:
229:
193:
185:
157:
466:
Venter, J. Craig; Adams, Mark D.; Myers, Eugene W.; et al. (16 February 2001).
591:
560:
487:
431:
423:
260:
Celera sequenced the human genome at a fraction of the cost of the publicly funded
621:
U.S. National
Institutes of Health website for the Human Genome Research Institute
452:
397:
595:
289:
250:
152:
564:
390:
629:
427:
400:
Quest
Diagnostics Successfully Completes Acquisition of Celera, May 17, 2011.
56:
492:
467:
298:
The Common Thread: A Story of
Science, Politics, Ethics and the Human Genome
501:
333:
293:
221:
192:, spun off into an independent company in 2008, and finally acquired by
313:
233:
48:
37:
216:), it was established in May 1998 by PE Corporation (later renamed to
246:
209:
116:
265:
217:
189:
237:
62:
253:
of Applera, along with the tracking stock of Applera's larger
346:
329:
620:
609:
412:"Dispute as rival groups publish details of human genome"
228:(TIGR) as its first president. While at TIGR, Venter and
168:
307:
300:. Anthropologist Paul Rabinow also based his 2005 book
582:Norman, Peter (September 2004). "Celera Genomics".
465:
627:
540:Newspaperarticle from "Handelsblatt", 2000-10-12
666:Biotechnology companies of the United States
615:Prepared Statement of Craig Venter of Celera
656:Biotechnology companies established in 1998
391:https://www.celera.com/celera/pr_1305673632
491:
435:
367:"Company Profile for Celera Group (CRA)"
641:Companies formerly listed on the Nasdaq
554:
359:
14:
646:Companies based in Alameda, California
628:
581:
557:Islamic Ethics and the Genome Question
514:
137:Scientific & Technical Instruments
584:Expert Opinion on Therapeutic Patents
459:
409:
308:Genomes sequenced by Celera Genomics
232:led the first successful effort to
27:American genetic sequencing company
24:
548:
468:"The Sequence of the Human Genome"
226:The Institute for Genomic Research
25:
682:
603:
268:. Celera's approach, which used
36:
661:1998 establishments in Maryland
533:
508:
410:Yamey, G. (17 February 2001).
403:
384:
332:, specifically mostly that of
13:
1:
671:2011 mergers and acquisitions
352:
515:Singer, Emily (2007-09-04).
204:Originally headquartered in
7:
83:; 26 years ago
10:
687:
636:Research support companies
596:10.1517/13543776.14.9.1345
302:A Machine to Make a Future
199:
565:10.1163/9789004392137_011
163:
151:
141:
133:
106:
95:
77:
69:
54:
44:
35:
428:10.1136/bmj.322.7283.381
517:"Craig Venter's Genome"
493:10.1126/science.1058040
323:Drosophila melanogaster
651:Life sciences industry
243:Haemophilus influenzae
522:MIT Technology Review
257:Group business unit.
236:an entire organism's
559:. pp. 241–249.
262:Human Genome Project
484:2001Sci...291.1304V
478:(5507): 1304–1351.
214:Alameda, California
184:is a subsidiary of
143:Number of employees
100:Alameda, California
32:
396:2011-07-09 at the
270:shotgun sequencing
255:Applied Biosystems
182:Celera Corporation
115:William G. Green (
31:Celera Corporation
30:
574:978-90-04-39212-0
340:Anopheles gambiae
194:Quest Diagnostics
186:Quest Diagnostics
179:
178:
158:Quest Diagnostics
122:Kathy P Ordonez (
16:(Redirected from
678:
599:
590:(9): 1345–1349.
578:
542:
537:
531:
530:
512:
506:
505:
495:
463:
457:
456:
439:
407:
401:
388:
382:
381:
379:
378:
369:. Archived from
363:
175:
172:
170:
91:
89:
84:
40:
33:
29:
21:
686:
685:
681:
680:
679:
677:
676:
675:
626:
625:
610:Company website
606:
575:
551:
549:Further reading
546:
545:
538:
534:
513:
509:
464:
460:
408:
404:
398:Wayback Machine
389:
385:
376:
374:
365:
364:
360:
355:
310:
220:), with Dr. J.
202:
167:
144:
129:
109:
102:, United States
87:
85:
82:
59:
28:
23:
22:
18:Celera Genomics
15:
12:
11:
5:
684:
674:
673:
668:
663:
658:
653:
648:
643:
638:
624:
623:
618:
612:
605:
604:External links
602:
601:
600:
579:
573:
550:
547:
544:
543:
532:
507:
458:
402:
383:
357:
356:
354:
351:
350:
349:
344:
336:
327:
309:
306:
290:Nobel laureate
286:The Genome War
251:tracking stock
240:, that of the
230:Hamilton Smith
212:(relocated to
201:
198:
177:
176:
165:
161:
160:
155:
149:
148:
145:
142:
139:
138:
135:
131:
130:
128:
127:
120:
112:
110:
107:
104:
103:
97:
93:
92:
79:
75:
74:
71:
67:
66:
60:
55:
52:
51:
46:
42:
41:
26:
9:
6:
4:
3:
2:
683:
672:
669:
667:
664:
662:
659:
657:
654:
652:
649:
647:
644:
642:
639:
637:
634:
633:
631:
622:
619:
616:
613:
611:
608:
607:
597:
593:
589:
585:
580:
576:
570:
566:
562:
558:
553:
552:
541:
536:
529:
524:
523:
518:
511:
503:
499:
494:
489:
485:
481:
477:
473:
469:
462:
454:
450:
447:
443:
438:
433:
429:
425:
422:(7283): 381.
421:
417:
413:
406:
399:
395:
392:
387:
373:on 2011-11-16
372:
368:
362:
358:
348:
345:
342:
341:
337:
335:
331:
328:
325:
324:
320:
319:
318:
316:
315:
305:
303:
299:
295:
291:
287:
282:
279:
273:
271:
267:
263:
258:
256:
252:
248:
245:
244:
239:
235:
231:
227:
223:
219:
215:
211:
207:
197:
195:
191:
187:
183:
174:
166:
162:
159:
156:
154:
150:
146:
140:
136:
132:
125:
121:
118:
114:
113:
111:
105:
101:
98:
94:
80:
76:
72:
68:
64:
61:
58:
53:
50:
47:
43:
39:
34:
19:
587:
583:
556:
535:
526:
520:
510:
475:
471:
461:
419:
415:
405:
386:
375:. Retrieved
371:the original
361:
338:
334:Craig Venter
321:
312:
311:
301:
297:
296:in his book
294:John Sulston
285:
283:
274:
259:
241:
222:Craig Venter
203:
181:
180:
96:Headquarters
45:Company type
326:(fruit fly)
304:on Celera.
278:open access
630:Categories
453:1777608398
377:2008-10-22
353:References
343:(mosquito)
314:Eukaryotes
108:Key people
73:Technology
65:: CRA
49:Subsidiary
446:A71350527
247:bacterium
206:Rockville
196:in 2011.
124:president
57:Traded as
502:11181995
449:ProQuest
394:Archived
234:sequence
210:Maryland
134:Products
117:chairman
70:Industry
480:Bibcode
472:Science
437:1119622
266:GenBank
218:Applera
200:History
190:Applera
171:.celera
164:Website
86: (
78:Founded
571:
500:
451:
444:
434:
238:genome
153:Parent
63:Nasdaq
347:Mouse
330:Human
224:from
569:ISBN
528:own.
498:PMID
442:Gale
292:Sir
173:.com
88:1998
81:1998
592:doi
561:doi
488:doi
476:291
432:PMC
424:doi
420:322
416:BMJ
169:www
147:554
632::
588:14
586:.
567:.
525:.
519:.
496:.
486:.
474:.
470:.
440:.
430:.
418:.
414:.
317::
208:,
598:.
594::
577:.
563::
504:.
490::
482::
455:.
426::
380:.
126:)
119:)
90:)
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
